Optimising platelet usage during the induction therapy of acute myeloid leukaemia: Impact of physician education.
John GnanarajAbhishekh BasavarajegowdaSmita KayalDibyajyothi SahooEsha TooraBiswajit DubashiPrasanth GanesanPublished in: Transfusion medicine (Oxford, England) (2023)
A short-duration education programme supplemented with weekly WhatsApp messages and an active feedback mechanism on the rationale of platelet transfusion by the treating physician and transfusion specialist could significantly reduce platelet consumption during the therapy of acute myeloid leukaemia patients. This is a measure that can be considered by all high-volume haematology centres, which can improve patient safety and reduce costs.
Keyphrases
- patient safety
- quality improvement
- liver failure
- end stage renal disease
- primary care
- emergency department
- healthcare
- respiratory failure
- cardiac surgery
- bone marrow
- dendritic cells
- newly diagnosed
- acute myeloid leukemia
- ejection fraction
- chronic kidney disease
- drug induced
- palliative care
- peritoneal dialysis
- clinical trial
- aortic dissection
- sickle cell disease
- study protocol
- intensive care unit
- extracorporeal membrane oxygenation